Search the Newsreel

Jefferies cuts STAAR Surgical stock price target on estimate update

Jefferies has lowered its price target for STAAR Surgical (NASDAQ:STAA) to $28 from $29, while maintaining a Hold rating, following the company's second-quarter 2026 results. STAAR Surgical reported Q2 revenue of $93.5 million, beating consensus estimates, with strong China sales, but missed earnings per …

STAAR Surgical Company Q2 2026 Earnings Call Summary

STAAR Surgical reported record first-half revenue, driven by the successful launch of EVO Plus in China, which helped gain market share despite a challenging refractive market. The company is strategically shifting to a platform approach, with plans for new product development and a transition …

STAAR Surgical Company Stock 12‑Month Price Target Cut to $28.89, Implies 14% Upside

STAAR Surgical Company's average 12-month price target has been reduced to $28.89 from $29.33, according to estimates from 9 analysts. This updated target suggests a potential upside of approximately 14% based on the August 12 closing price. The consensus rating for the stock remains …

Piper Sandler reiterates Neutral on STAAR Surgical stock at $33

Piper Sandler reiterated a Neutral rating on STAAR Surgical (NASDAQ:STAA) with a $33.00 price target, following the company's second-quarter results. While STAAR Surgical's China business exceeded expectations, generating $52.3 million in revenue, the company missed revenue expectations in other key regions like the United …

STAAR Surgical (NASDAQ:STAA) Shares Gap Down Following Analyst Downgrade

STAAR Surgical (NASDAQ:STAA) Price Target Lowered to $37.00 at Wedbush

Wedbush has lowered its price target for STAAR Surgical (NASDAQ:STAA) to $37.00 from $40.00 but maintained an "outperform" rating, indicating a potential upside of 45.61%. Despite this, analyst sentiment is mixed, with an average "hold" rating and a consensus price target of $26.61. The …

Intuitive Surgical (ISRG) Backs Long-Term Moat Amid Near-Term Volatility

TCW Funds, an investment management firm, published its second-quarter 2026 investor letter for the 'TCW Concentrated Large Cap Growth Fund.' A copy of the letter can be downloaded here. During the second quarter, AI monetization, a fragile Middle East ceasefire, and a Federal Reserve …

STAAR Surgical earnings beat by $0.02, revenue topped estimates

STAAR Surgical: China Generates More Than Half Of Q2 Revenue As Total Sales Jump 111%

STAAR Surgical reported a 111% year-over-year jump in Q2 2026 net sales to $93.5 million, with China contributing over half of this revenue at $52.3 million. The company saw significant profitability improvements, including a gross margin increase to 74.5% and net income of $8.1 …

STAAR Surgical Q2 Sales Surge, Fueled by China as Key Market

STAAR Surgical (NASDAQ: STAA) announced significant Q2 2026 financial results, with net sales reaching $93.5 million, an 111 percent increase year-over-year. This surge was primarily driven by the Chinese market, which accounted for over half of the quarterly revenue. The company also reported improvements …

Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)

The outpatient and specialty care industry showed strong Q2 results, with revenues beating analysts' consensus estimates. Surgery Partners (NASDAQ:SGRY) reported a 2.7% year-on-year revenue increase to $848.9 million, exceeding expectations, but delivered the slowest revenue growth and weakest full-year guidance among its peers. In …

STAAR Surgical Q2 Earnings Call Highlights

Key Points Interested in STAAR Surgical Company? Here are five stocks we like better. STAAR Surgical reported a strong second quarter: Net sales more than doubled to $93.5 million, while the company returned to profitability with $8.1 million in net income and $20 million …

Pomona hospital upgrades its surgical robots

Pomona Valley Hospital Medical Center has upgraded its surgical robot system by acquiring three of the latest Intuitive da Vinci 5 surgical systems. This new fleet of technology offers improved resolution, more realistic 3D imaging, and applies significantly less force on tissue, benefiting patients …

Why STAAR Surgical (STAA) Is Getting Fresh Attention Now

STAAR Surgical (NASDAQ:STAA) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPS

The Real Price of Intuitive Surgical Stock's Robotic Future

Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Intuitive Surgical (ISRG) shook investors after reporting strong Q2 2026 revenue and earnings that beat expectations, while revealing slower U.S. procedure growth and …

Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates

Staar Surgical (STAA) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 CY2026 Numbers But Stock Drops

STAAR Surgical (NASDAQ:STAA) reported strong Q2 CY2026 results, with revenue up 111% year-on-year to $93.54 million, exceeding analyst expectations, and GAAP EPS of $0.16, beating estimates by 12.6%. Despite these positive numbers, the stock dropped 8% immediately after the announcement. The company's operating margin …

STAAR Surgical Q2 2026 Earnings: China Rebound Restores Profitability

Earnings Flash (STAA) STAAR Surgical Company Reports Q2 Revenue $93.5M, vs. FactSet Est of $90.6M

STAAR Surgical Company (STAA) reported its Q2 revenue of $93.5 million, surpassing FactSet's estimate of $90.6 million. This financial update indicates a positive performance for the medical equipment company during the second quarter. The article provides a brief overview of the company's recent earnings.

Insider Selling: Intuitive Surgical (NASDAQ:ISRG) Director Sells $4,000,000.00 in Stock

Intuitive Surgical director Gary Guthart sold 10,000 shares of company stock for $4 million at $400 per share under a pre-arranged Rule 10b5-1 trading plan. Despite a strong financial quarter with revenue up 18.4% and earnings beating estimates, investor concerns about slowing domestic procedure …

Intuitive Surgical director Gary Guthart sells $4m in stock

Gary S. Guthart, a director at Intuitive Surgical Inc. (NASDAQ:ISRG), sold 10,000 shares of company stock for $4 million on August 11, 2026, under a pre-arranged trading plan. Following the sale, Guthart still directly holds over 1.2 million shares, with additional shares held indirectly …

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …

Intuitive Surgical (ISRG) director reports 10,000-share trust sale under 10b5-1 plan

Intuitive Surgical (ISRG) director Gary S. Guthart reported an indirect sale of 10,000 common shares by a trust on August 11, 2026, at $400.00 per share, under a Rule 10b5-1 trading plan. Following the transaction, the trust holds 1,245,679 shares, with additional indirect holdings …

Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says

Intuitive Surgical's (ISRG) competitors face unique workflow challenges and real estate issues that impact their long-term appeal, while customized price-volume contracts complicate competitors' return on investment and its flexible per-click model allows growth opportunities in Silver Upgrade to read this MT Newswires article and …

This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Several top Wall Street analysts have updated their ratings for key companies. Mizuho upgraded IDEX Corp to Outperform, Deutsche Bank upgraded Entegris Inc to Buy, Oppenheimer upgraded Intuitive Surgical Inc to Outperform, and Citizens upgraded Okta Inc to Market Outperform, all with increased price …

Surge Energy (TSE:SGY) Reaches New 12-Month High - What's Next?

Intuitive Surgical (ISRG) Stock Has Plunged 33% in 2026. Here's Why One Fund Manager Remains Bullish -- and Why I Do, Too.

Key Points The robotic surgery specialist has over 12,000 installed systems globally. Right now, it's facing some headwinds, but it also has a lot going for it. The Baron Health Care Fund sees Intuitive Surgical as full of promise.10 stocks we like better than …

Intuitive Surgical: Oppenheimer now bullish, sees competition being "crowded out"

Investing.com -- Oppenheimer upgraded Intuitive Surgical to Outperform from Perform with a $500 price target in a note on Wednesday, arguing the company's strategy of "Crowding Out Competitors" is strategically smart. Analyst Suraj Kalia said the change reflects "a more nuanced risk-reward assessment at …

If You Invested $1000 in Intuitive Surgical, Inc. 10 Years Ago, This Is How Much You'd Have Now

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

Intuitive Surgical upgraded at Oppenheimer on robotic surgery market growth

Oppenheimer has upgraded Intuitive Surgical (ISRG) to outperform, citing the company's strong position to benefit from the growing robotic surgery market. Despite increasing competition from companies like Johnson & Johnson (JNJ), Oppenheimer believes Intuitive Surgical will maintain its market dominance. This upgrade reflects confidence …

Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold

Zacks Research downgraded Surgery Partners (NASDAQ:SGRY) from "Strong Buy" to "Hold," leading to a 6% drop in the stock price despite the company exceeding Q2 earnings and revenue estimates. While the broader analyst consensus remains a "Moderate Buy" with an average target of $19.45, …

Aroa Biosurgery (ASX:ARX) Profit Milestone Shifts Focus to US Growth Strategy

Annex Advisory Services LLC Raises Stock Position in Intuitive Surgical, Inc. $ISRG

Annex Advisory Services LLC has increased its stake in Intuitive Surgical (NASDAQ:ISRG) by 37.4% in the second quarter, bringing its total holdings to 90,943 shares valued at $36.2 million. This comes as Intuitive Surgical reported strong Q2 results, with revenue up 18.4% and EPS …